Arjan Diepstra
dr.
As a hematopathologist, I work on diagnostics of all types of hematological malignancies using a comprehensive panel of different techniques. Moreover, my main research interest involves Hodgkin lymphoma, with a strong focus on interactions between tumor cells and the microenvironment. In addition, I also have a long standing interest in genetic susceptibility. My areas of expertise are: immunology, tumor cell biology, genetic association studies and molecular diagnostics in pathology. I actively participate in international (EORTC) and national (HOVON) clinical trials.
Latest publications
(216)
Activities
(38)
Press/Media
(7)
Prizes
(4)
Datasets
(1)
Supervised work
(12)
HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBVI Hodgkin lymphoma
Published in: Blood
Access to document
10.1182/blood-2007-05-086934
Previous studies showed that the HLA class I region is associated with Epstein-Barr virus (EBV)-positive Hodgkin lymphoma (HL) and that HLA-A is the most likely candidate gene in this region. This suggests that antigenic presentation of EBV-derived peptides in the context of HLA-A is involved in the pathogenesis of EBV+ HL by precluding efficient immune responses. We genotyped exons 2 and 3, encoding the peptide-binding groove of HLA-A, for 32 single nucleotide polymorphisms in 70 patients with EBV+ HL, 31 patients with EBV- HL, and 59 control participants....
Marijke Niens, Ruth F. Jarreft, Bouke Hepkema, Ilja M. Nolte, Arjan Diepstra, Mathieu Platteel, Niels Kouprie, Craig P. Delury, Alice Gallagher, Lydia Visser, Sibrand Poppema, Gerard J. te Meerman, Anke Van den Berg
HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin’s lymphoma
Published in: Journal of Clinical Oncology
Access to document
10.1200/JCO.2006.10.0917
Purpose The neoplastic Hodgkin Reed-Sternberg ( HRS) cells in classical Hodgkin’s lymphoma ( cHL) are derived from B cells. The frequency of HLA class II downregulation and its effect on prognosis are unknown. Patients and Methods Immunohistochemistry results for HLA class II were evaluated in 292 primary cHL patients in a population-based approach. Patients were diagnosed between 1989 and 2000 in the northern part of the Netherlands. Median age at diagnosis was 38 years ( range, 8 to 88 years); 63% had Ann Arbor stage I or II,...
Arjan Diepstra, Gustaaf W. van Imhoff, Henrike E. Karim-Kos, Anke van den Berg, Gerard J. te Meerman, Marijke Niens, Ilja M. Nolte, Esther Bastiaannet, Michael Schaapveld, Edo Vellenga, Sibrand Poppema
Global correlation of genome and transcriptome changes in classical Hodgkin lymphoma
Published in: HEMATOLOGICAL ONCOLOGY
Access to document
10.1002/hon.804
To identify genes involved in the pathogenesis of classical Hodgkin lymphoma (cHL), we performed serial analysis of gene expression (SAGE) and array-based comparative genomic hybridization (aCGH). Comparison of SAGE libraries of cHL cell lines L428 and L1236 with that of germinal centre B cells revealed consistent overexpression of only 14 genes. In contrast, 141 genes were downregulated in both cHL cell lines, including many B cell and HLA genes. aCGH revealed gain of 2p, 7p, 9p, 11q and Xq and loss of 4q and 11q. Eighteen percent of...
Joost Kluiver, Klaas Kok, Ines Pfeil, Debora de Jong, Tjasso Blokzijl, Geert Harms, Pieter van der Vlies, Arjan Diepstra, Cigdem Atayar, Sibrand Poppema, Ralf Kueppers, Anke van den Berg
Classical Hodgkin lymphoma: population based studies on HLA and EBV
Classical HL is a hematological malignancy in which immunological interactions are crucially involved. The neoplastic HRS cells use a variety of strategies to evade immune reactions, but also shape the immune response to their own benefit. Antigen presentation may be involved in both of these mechanisms. The significance of antigen presentation is supported by an inherited susceptibility to cHL that has been associated with HLA class I and HLA class II alleles and haplotypes (the sequence of alleles on one chromosome; chapter 2). Because antigenic peptides derived from...
The human leukocyte antigen class I region is associated with EBV-positive Hodgkin’s lymphoma: HLA-A and HLA complex group 9 are putative candidate genes
Published in: Cancer Epidemiology, Biomarkers & Prevention
Access to document
10.1158/1055-9965.EPI-06-0476
Various studies have indicated that the human leukocyte antigen (HLA) region is associated with Hodgkin’s lymphoma. We recently showed a specific association of the HLA class I region with EBV-positive Hodgkin’s lymphoma cases. One haplotype of two consecutive microsatellite markers (D6S265 and D6S510) was overrepresented in the patient group, whereas another haplotype was underrepresented. Here, we did fine mapping of this region of -400 kb as a next step to find the causative single-nucleotide polymorphism(s) (SNP). To select candidate SNPs for screening the total study population, several known...
Marijke Niens, Anke van den Berg, Arjan Diepstra, Ilja M. Nolte, Gerrit van der Steege, Alice Gallagher, G. Malcolm Taylor, Ruth F. Jarrett, Sibrand Poppema, Gerard J. te Meerman